Gender differences in stem cell population are induced by pregnancy

被引:4
作者
El-Badri, Nagwa S. [1 ]
Groer, Maureen [2 ]
机构
[1] Univ S Florida, Dept Obstet Gynecol, Coll Med, Tampa, FL 33612 USA
[2] Univ S Florida, Coll Nursing, Tampa, FL 33612 USA
关键词
CORONARY-HEART-DISEASE; PROGENITOR CELLS; FETAL CELLS; BONE-MARROW; WOMEN; MICROCHIMERISM; MENOPAUSE; TOLERANCE; BLOOD;
D O I
10.1016/j.mehy.2012.06.029
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Gender differences in stem cell population have recently been identified. Blood and tissue samples from women showed consistent elevation of hematopoietic stein cell populations, mesenchymal stem cell populations and endothelial progenitor cells compared to men of similar ages. We and others have shown an increase in hematopoietic stem cell population in pregnant and multiparous women compared to nulliparous women. We propose that pregnancy exposes women to increased levels of stem cells from many sources not available for nulliparous women or for men. During pregnancy, maternal fetal microchimerism results from trafficking of fetal and maternal blood across the placenta. Physiological changes in the maternal blood cellular milieu are also recognized during pregnancy and in the early post partum due to the presence of unique pregnancy associated tissues and hormones. The e include the placenta, the amniotic fluid and cord blood. These tissues are highly enriched for different populations of stem cells including hematopoietic stem cells, mesenchymal stem cells and endothelial progenitor cells. Recent studies showed accelerated healing in women affected by cardiovascular insults and stroke, in part due to faster tissue regeneration and stem cell activity. We propose that gender differences in stem cell population are caused in part due to maternal exposure to fetal and unique pregnancy associated tissues, which are significantly enriched in different stem cell populations. (C) 2012 Published by Elsevier Ltd.
引用
收藏
页码:481 / 483
页数:3
相关论文
共 28 条
[1]   Tolerance, suppression and the fetal allograft [J].
Aluvihare, VR ;
Kallikourdis, M ;
Betz, AG .
JOURNAL OF MOLECULAR MEDICINE-JMM, 2005, 83 (02) :88-96
[2]   Significant fetal-maternal hemorrhage after termination of pregnancy: Implications for development of fetal cell microchimerism [J].
Bianchi, DW ;
Farina, A ;
Weber, W ;
Delli-Bovi, LC ;
DeRiso, M ;
Williams, JM ;
Klinger, KW .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2001, 184 (04) :703-706
[3]   Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum [J].
Bianchi, DW ;
Zickwolf, GK ;
Weil, GJ ;
Sylvester, S ;
DeMaria, MA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (02) :705-708
[4]   Fetomaternal cell traffic, pregnancy-associated progenitor cells, and autoimmune disease [J].
Bianchi, DW .
BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY, 2004, 18 (06) :959-975
[5]   Concentration of circulating endothelial progenitor cells (EPC) in normal pregnancy and in pregnant women with diabetes and hypertension [J].
Buemi, Michele ;
Allegra, Alessandro ;
D'Anna, Rosario ;
Coppolino, Giuseppe ;
Crasci, Eleonora ;
Giordano, Domenico ;
Loddo, Saverio ;
Cucinotta, Maria ;
Musolino, Caterina ;
Teti, Diana .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2007, 196 (01) :68-69
[6]   TROPHOBLAST IN THE CIRCULATING BLOOD DURING PREGNANCY [J].
DOUGLAS, GW ;
THOMAS, L ;
CARR, M ;
CULLEN, NM ;
MORRIS, R .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1959, 78 (05) :960-&
[7]  
El-Badri Nagwa S, 2008, Biosci Hypotheses, V1, P100, DOI 10.1016/j.bihy.2008.02.012
[8]  
Gill M, 2001, CIRC RES, V88, P167
[9]  
Groer M, 2012, SGI 59 ANN SCI M, P21
[10]   Fetal Microchimerism and Women's Health: A New Paradigm [J].
Groer, Maureen W. ;
Manion, Maura ;
Szekeres, Charles ;
El-Badri, Nagwa S. .
BIOLOGICAL RESEARCH FOR NURSING, 2011, 13 (04) :346-350